Andrew E. Arrant

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia”.

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Journal of Translational Medicine(2023)10.1186/s12967-023-04251-y

N/A

1.2DataRank · unranked

52 citations

Ananya Mitra, Tina Schwabe, Robert Paul, Andrew E. Arrant, Erik D. Roberson +5 more

Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations

Acta Neuropathologica Communications(2023)10.1186/s40478-023-01571-4

N/A

0.592DataRank · unranked

15 citations

Anna K. Cook, Justin A. Hall, Yuliya Voskobiynyk, Nancy V. Carullo, Nicholas R. Boyle +16 more

Adolescent stress accelerates postpartum novelty recognition impairment in 5xFAD mice

Frontiers in Neuroscience(2024)10.3389/fnins.2024.1366199

N/A

0DataRank · unranked

3 citations

José Fernando de Oliveira, Shaimaa M. Khedr, Lila Ariste, Stefanie Robel, Shin‐ichi Kano +3 more

Carboxy-terminal blockade of sortilin binding enhances progranulin gene therapy, a potential treatment for frontotemporal dementia

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.15.613118

N/A

0DataRank · unranked

3 citations

Stephanie N. Fox, Katherine I. Wilson, Charles Murchison, Yohannes A. Ambaw, Tobias C. Walther +4 more